Neuroblastoma Market - Top Companies and Manufacturers

Companies Dominating the Neuroblastoma Landscape

Merck & Co., Inc.,
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Pfizer Inc.
United Therapeutics Corporation
APEIRON Biologics AG
Sanofi S.A.
Bayer AG
Sun Pharmaceutical Industries Ltd.
Y- mabs Therapeutics Inc.
Baxter International Inc.
Cellectar Biosciences

Browse Key Market Insights with Data Illustration:

Neuroblastoma Market Size, Growth | Trends Analysis 2036

In the News

An acquisition of Acceleron Pharma Inc., by Merck & Co., has been successfully completed. Merck & Co. sought to acquire Acceleron Pharma Inc. in order to expand its portfolio of biopharmaceuticals and build on its current capabilities in the biopharma space. The acquisition will give Merck & Co. access to Acceleron Pharma Inc.'s pipeline of potential new medicines and technologies, as well as provide the ability to better serve patients around the world.
An agreement has been signed by Pfizer Inc. and Seagen Inc. whereby Pfizer intends to acquire Seagen, a global biotechnology company focused on discovering, developing, and commercializing transformative cancer medicines, with a total enterprise value of USD 43 billion for each Seagen share at USD 229 in cash.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of neuroblastoma is estimated at USD 3.15 Billion.

The neuroblastoma market size was over USD 3.03 Billion in 2023 and is projected to cross USD 5.37 Billion by the end of 2036, witnessing more than 4.5% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of neuroblastoma, the growing awareness about the disease, and the availability of new treatments are the major factors driving the market growth.

North America industry is anticipated to have the highest growth through 2036, backed by increasing healthcare expenditure, and the rising number of hospitals in the region

Merck & Co., Inc., Pfizer Inc., United Therapeutics Corporation, APEIRON Biologics AG, Sanofi S.A., Bayer AG, Sun Pharmaceutical Industries Ltd., Y- mabs Therapeutics Inc., Baxter International Inc., Cellectar Biosciences

Neuroblastoma Market - Top Companies and Manufacturers

Companies Dominating the Neuroblastoma Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the neuroblastoma market?

Why is the neuroblastoma sector gaining traction in near future?

Which region accounted for the largest neuroblastoma industry share?

Who are the major neuroblastoma players?